Recent Updates
Recently added Catalysts
JAZZ

Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at three upcoming investor...

Key Takeaway: DUBLIN , May 9, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the company will be webcasting its corporate presentations at three upcoming investor conferences. A live audio webcast of each presentation may be accessed from the Investors sect

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+46%
120-day peak, hindsight
Typical move
2.1%
average across 9 past catalysts
Lead asset
GWP42004
Phase 2 · Diabetes Mellitus, Type 2

Full Press Release Details

DUBLIN , May 9, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the company will be webcasting its corporate presentations at three upcoming investor conferences.
A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at http://www.jazzpharmaceuticals.com . Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
An archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at http://www.jazzpharmaceuticals.com .
Last updated: May 9, 2018